Simvastatin
Cat.No:IS0170 Solarbio
CAS:79902-63-9
Molecular Formula:C25H38O5
Molecular Weight:418.57
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Metabolic Enzyme & Protease > SimvastatinCAS:79902-63-9
Molecular Formula:C25H38O5
Molecular Weight:418.57
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
| CAS | 79902-63-9 |
| Name | Simvastatin |
| Molecular Formula | C25H38O5 |
| Molecular Weight | 418.57 |
| Solubility | Soluble in DMSO/Ethanol ≥5mg/mL |
| Purity | HPLC≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| EC | EINECS 404-520-2 |
| MDL | MFCD00072007 |
| SMILES | CCC(C)(C)C(O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(O3)=O)[C@@]12[H])=O |
| InChIKey | RYMZZMVNJRMUDD-HGQWONQESA-N |
| InChI | InChI=1S/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1 |
| PubChem CID | 54454 |
| Target Point | HMG-CoA Reductase (HMGCR) |
| Passage | Metabolic Enzyme&Protease |
| Background | Simvastatin is a competitive HMG-CoA reductase inhibitor. |
| Biological Activity | Simvastatin 是一种竞争性的 HMG-CoA reductase 抑制剂, Ki 值为 0.2 nM[1]。 |
| IC50 | Ki: 0.2nM (HMG-CoA reductase) [1] |
| Data Literature Source | [1]. Slater, E.E., et al. Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative. Drugs, 1988. 36 Suppl 3: p. 72-82. [2]. Kureishi, Y., et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med, 2000. 6 (9) : p. 1004-10. [3]. Leung BP, et al. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol. 2003 Feb 1; 170 (3) :1524-30. [4]. Kobayashi M, et al. Preventive effect of MK-733 (simvastatin) , an inhibitor of HMG-CoA reductase, on hypercholesterolemia and atherosclerosis induced by cholesterol feeding in rabbits. Jpn J Pharmacol. 1989 Jan; 49 (1) :125-33. [5]. Ishida F, et al. Comparative effects of simvastatin (MK-733) and pravastatin (CS-514) on hypercholesterolemia induced by cholesterol feeding in rabbits. Biochim Biophys Acta. 1990 Feb 23; 1042 (3) :365-73. [6]. Sukhova GK, et al. Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol. Arterioscler Thromb Vasc Biol. 2002 Sep 1; 22 (9) :1452-8. [7]. Weijiang Dong, et al. Differential effects of simvastatin and pravastatin on expression of Alzheimer’s disease-related genes in human astrocytes and neuronal cells. J Lipid Res. 2009 Oct; 50 (10) : 2095-2102. [8]. Liu Z, et al. Pretreatment Donors after Circulatory Death with Simvastatin Alleviates Liver Ischemia Reperfusion Injury through a KLF2-Dependent Mechanism in Rat. Oxid Med Cell Longev. 2017; 2017:3861914 |
| Unit | Bottle |
| Specification | 100mg 10mM*1mL in DMSO 200mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Ligusticum chuanxiong prevents high-fat-diet-induced lipid metabolism disorder in mice by modulating the genes in the cholesterol pathway
Click to check >>Author:Huifang Ge, Xianjiang Ye, Qihe Chen, Jia Ye, Jicheng Chen
IF:9.9000
Publish_to:Food Frontiers
PMID:
PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling
Click to check >>Author:Chen Hualin, Yang Wenjie, Li Yingjie, Ji Zhigang
IF:9.0000
Publish_to:Cell Death & Disease
PMID:37454211
Hepatoprotective Effect and Molecular Mechanisms of Hengshun Aromatic Vinegar on Non-Alcoholic Fatty Liver Disease
Click to check >>Author:Zhu S; Guan L; Tan X; Li G; Sun C; Gao M; Zhang B; Xu L.
IF:5.6000
Publish_to:Frontiers in Pharmacology
PMID:33343352
Corilagin ameliorates atherosclerosis by regulating MMP-1; -2; and -9 expression in vitro and in vivo
Click to check >>Author:Tao Y; Zhang L; Yang R; Yang Y; Jin H; Zhang X; Hu
IF:5.1950
Publish_to:Eur J Pharmacol
PMID:34062170
Metformin Delays the Development of Atherosclerosis in Type 1 Diabetes Mellitus via the Methylglyoxal Pathway
Click to check >>Author:LiuA;LiK;XuL;SiM;TengG;LiG;XueJ;LiangS;SongW
IF:2.4820
Publish_to:Diabetes Ther
PMID:31955370
Manual Download